Study Period (Dates covered) | Oct. 20 – Dec. 20, 2021 |
---|---|
Assumed COVID-19 Epidemiological Characteristics | |
Latent period durationa | 2 days |
Basic reproduction numberb | R0 = 5 |
% cases asymptomaticc | 40% |
Infectiousness of asymptomatic casesd | 75% |
% vaccinated in general populatione | 53.8% |
Vaccine effectivenessf | 88% |
Immunity durationg | 180 days |
Inputs Specific to COVID-19 Mask Mandate | |
Mask effectivenessh | |
Pre-mandate | 3.6% – 16.8% |
Post-mandate | 6.1% – 21.3% |
Inputs Specific to COVID-19 Vaccinate-or-Test Requirement | |
Size of the population affected by requirementi | 929,370 |
% vaccinated in sub-population affected by requirementj | |
Pre-requirement | 64.8% |
Post-requirement | 75.9% |